Insmed
INSM
$25.59
Share price
3.52%
Change (1 day)
26.87%
Change (1 year)
Categories
Insmed (INSM) - Total assets
Total assets on the balance sheet as of December 2023 : $1.32 B
According to Insmed's latest financial reports the company's total assets are $1.32 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Insmed - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.32 B | -19.72% |
| 2022-12-31 | $1.65 B | 33.21% |
| 2021-12-31 | $1.24 B | 56.19% |
| 2020-12-31 | $0.79 B | 7.26% |
| 2019-12-31 | $0.74 B | 22.78% |
| 2018-12-31 | $0.60 B | 30.84% |
| 2017-12-31 | $0.46 B | 94.17% |
| 2016-12-31 | $0.23 B | -33.26% |
| 2015-12-31 | $0.35 B | 54.44% |
| 2014-12-31 | $0.23 B | 30.8% |
| 2013-12-31 | $0.17 B | 14.94% |
| 2012-12-31 | $0.15 B | 9.82% |
| 2011-12-31 | $0.13 B | -28.75% |
| 2010-12-31 | $0.19 B | 54.91% |
| 2009-12-31 | $0.12 B | 2562.78% |
| 2008-12-31 | $4.75 M | -75.6% |
| 2007-12-31 | $19.5 M | -31.21% |
| 2006-12-31 | $28.34 M | 23.95% |
| 2005-12-31 | $22.87 M | 75.77% |
| 2004-12-31 | $13.01 M | -56.36% |
| 2003-12-31 | $29.81 M | 5.31% |
| 2002-12-31 | $28.3 M | -60.47% |
| 2001-12-31 | $71.6 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 6,993.64% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $62.12 B | 4,571.61% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $22.73 B | 1,609.24% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $3.26 B | 145.49% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.37 B | -71.76% | 🇺🇸 USA |
 Array Technologies ARRY | $1.70 B | 28.34% | 🇺🇸 USA |